With companies racing to secure GLP-1-related assets, there may be risks for moving too fast.

Should the weight-loss pioneers be bracing for more lean years, then? Not necessarily. For although being first did not ...

The Cleveland Clinic found in a September report that individuals with a version of the gene Neurobeachin were more likely to ...

Novo Nordisk was downgraded to underweight by Morgan Stanley. Morgan Stanley analysts say a trial to test whether Novo Nordisk's blockbuster weight-loss drug also will work against Alzheimer's is ...

Weight loss injections seem to be more popular, but "compounded" versions of these drugs can vary in how people access them.

Eli Lilly's tirzepatide, marketed under the brands Mounjaro for diabetes and Zepbound for weight management, is highly ...

MANHATTAN — Kansas State football went into the week needing to show something that could instill confidence heading into the remainder of the season. It didn’t happen. Instead, the Wildcats are ...

Eli Lilly said in August that around 50 percent of employers had chosen to cover its weight-loss drug, Zepbound, little changed from a year earlier. Novo Nordisk said last month that about 40 million ...

WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial ...

Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are much cheaper and will not be affected by these tariffs.

Patients often don’t realize that the same procedure at different locations (even with the same insurance) can have very ...